In the News

Walgreens and Madison Dearborn Partners Announce Agreement for Walgreens Infusion Services

DEERFIELD, Ill., January 20, 2015 - Walgreen Co., a wholly owned subsidiary of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), today announced that it has signed a definitive agreement with Madison Dearborn Partners (MDP), a leading private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services.
Read More

Walgreens Flu Index™ for Week of Jan. 19, 2015

DEERFIELD, Ill., January 20, 2015 - The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country. With the ability to generate hyper-local data that’s as specific as a single zip code, the Index aims to drive consumer awareness and prevention within communities, while also serving as a valuable resource for health departments, media and others at the local level.
Read More

Walgreens Infusion Services Named a Limited Network Home Infusion Provider for New Continuous Intravenous Infusion Therapy BLINCYTO™ (blinatumomab) Immunotherapy

DEERFIELD, Ill., January 15, 2015 - Walgreens today announced that, effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for BLINCYTO™ (blinatumomab), a therapy for the treatment of patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). BLINCYTO™ can now be obtained through and administered by Walgreens Infusion Services.
Read More

Featured Multimedia

13 January 2015

Well Beyond HIV

For additional resources and details about the campaign, please visit
10 December 2014

Exterior Signage

More Videos

08 December 2014


More Photos